|
|
||||||||
Stem Cells, Vol 11, 336-347, Copyright © 1993 by AlphaMed Press
ORIGINAL ARTICLES |
RE Ploemacher, PL van Soest and A Boudewijn
Institute of Hematology, Erasmus University, Rotterdam, The Netherlands.
The ability of Steel Factor (SF) to stimulate colony formation and progenitor cell generation by hemopoietic stem cells (HSCs) in vitro in the absence of interleukin 3 (IL-3) was investigated. IL-3 was required for HSC proliferation, and no or restricted proliferation occurred in the presence of SF, IL-6, IL-11, or IL-12 as single factors or in combination. Neutralizing concentrations of anti-transforming growth factor (TGF)-beta 1 antibodies enhanced progenitor cell generation 2-3- fold in the presence of IL-3, but 75 to over 300-fold when cultures contained at least SF in the absence of IL-3. Exogenous TGF-beta 1 fully abrogated the antibody effects. In the presence of antibodies to TGF-beta 1, SF alone stimulated the delayed formation of small blast cell colonies and SF synergized with IL-6, IL-11, or IL-12 to greatly hasten colony formation, enhance colony number and size, and increase colony forming unit-culture (CFU-C) output from suspension cultures of enriched HSC populations. Secondary CFU-C colonies were significantly larger when IL-3 was absent during the suspension culture phase. Single cell and limiting dilution analysis using a homogenous colony forming unit-spleen (CFU-S) day-12 population and an 800-fold enriched long- term repopulating HSC fraction, respectively, indicated that TGF-beta 1 was an autocrine product of these HSC subsets. Addition of nucleosides, insulin, extra glucose, or serum could not replace the effects of the anti-TGF-beta 1 antibody. While these data offer one possible explanation for reports on the inability of SF to stimulate HSC proliferation, they present the basis for a novel model of the regulation of HSC activation wherein: 1) close-range interactions of HSCs with mesenchymal stromal cells do not exclusively determine maintenance of HSC quiescence; 2) competence acquisition by dormant HSCs may involve the down-regulation or inactivation of autocrine TGF- beta 1; and 3) SF may act as a primary growth factor rather than exclusively as a synergistic cytokine.
This article has been cited by other articles:
![]() |
R. A.J. Oostendorp, S. Gilfillan, A. Parmar, M. Schiemann, S. Marz, M. Niemeyer, S. Schill, E. Hammerschmid, V. R. Jacobs, C. Peschel, et al. Oncostatin M-Mediated Regulation of KIT-Ligand-Induced Extracellular Signal-Regulated Kinase Signaling Maintains Hematopoietic Repopulating Activity of Lin-CD34+CD133+ Cord Blood Cells Stem Cells, August 1, 2008; 26(8): 2164 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Moody, S. Singbrant, G. Karlsson, U. Blank, M. Aspling, J. Flygare, D. Bryder, and S. Karlsson Endoglin Is Not Critical for Hematopoietic Stem Cell Engraftment and Reconstitution but Regulates Adult Erythroid Development Stem Cells, November 1, 2007; 25(11): 2809 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Utsugisawa, J. L. Moody, M. Aspling, E. Nilsson, L. Carlsson, and S. Karlsson A Road Map Toward Defining the Role of Smad Signaling in Hematopoietic Stem Cells Stem Cells, April 1, 2006; 24(4): 1128 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Bohmer IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta Stem Cells, March 1, 2004; 22(2): 216 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Klarmann, M. Ortiz, M. Davies, and J. R. Keller Identification of in vitro growth conditions for c-Kit-negative hematopoietic stem cells Blood, November 1, 2003; 102(9): 3120 - 3128. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Akel, C. Petrow-Sadowski, M. J. Laughlin, and F. W. Ruscetti Neutralization of Autocrine Transforming Growth Factor-{beta} in Human Cord Blood CD34+CD38-Lin- Cells Promotes Stem-Cell-Factor-Mediated Erythropoietin-Independent Early Erythroid Progenitor Development and Reduces Terminal Differentiation Stem Cells, September 1, 2003; 21(5): 557 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fortunel, J. Hatzfeld, S. Kisselev, M.-N. Monier, K. Ducos, A. Cardoso, P. Batard, and A. Hatzfeld Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell-Surface TGF-{beta} Type II Receptor in a Short-Term In Vitro Assay Stem Cells, March 1, 2000; 18(2): 102 - 111. [Abstract] [Full Text] |
||||
![]() |
P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF] |
||||
![]() |
V. I. Rebel, S. Hartnett, G. R. Hill, S. B. Lazo-Kallanian, J. L.M. Ferrara, and C. A. Sieff Essential Role for the p55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level J. Exp. Med., November 15, 1999; 190(10): 1493 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.P. Kale and L.S. Limaye Stimulation of Adult Human Bone Marrow by Factors Secreted by Fetal Liver Hematopoietic Cells: In Vitro Evaluation Using Semisolid Clonal Assay System Stem Cells, March 1, 1999; 17(2): 107 - 116. [Abstract] [Full Text] |
||||
![]() |
A. J. Schilz, G. Brouns, O. G. Ottmann, D. Hoelzer, A. A. Fauser, A. J. Thrasher, and M. Grez High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free Conditions Blood, November 1, 1998; 92(9): 3163 - 3171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Valk, S. Verbakel, Y. Vankan, S. Hol, S. Mancham, R. Ploemacher, A. Mayen, B. Lowenberg, and R. Delwel Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells Blood, August 15, 1997; 90(4): 1448 - 1457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |